These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29978156)

  • 81. Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents.
    Oguma T; Nakayama K; Kuriyama C; Matsushita Y; Yoshida K; Hikida K; Obokata N; Tsuda-Tsukimoto M; Saito A; Arakawa K; Ueta K; Shiotani M
    J Pharmacol Exp Ther; 2015 Sep; 354(3):279-89. PubMed ID: 26105952
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature.
    Gajjar K; Luthra P
    Cureus; 2019 Apr; 11(4):e4384. PubMed ID: 31218148
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Severe hypertriglyceridemia: A rare complication of diabetic ketoacidosis in a 3-year-old with SARS-CoV-2 infection.
    Basta C; Ramones K; Agarwal S; Marino G; Ghanny S
    J Clin Transl Endocrinol Case Rep; 2021 Dec; 22():100099. PubMed ID: 34751241
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Use of a Computer-Based Insulin Infusion Algorithm to Treat Diabetic Ketoacidosis in the Emergency Department.
    Ullal J; McFarland R; Bachand M; Aloi J
    Diabetes Technol Ther; 2016 Feb; 18(2):100-3. PubMed ID: 26783996
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Post-Operative Euglycemic Diabetic Ketoacidosis in a Patient With SGLT-2 Inhibitor Use and Recent Sleeve Gastrectomy.
    Smith A; Holtrop J; Sadoun M
    Cureus; 2021 Apr; 13(4):e14297. PubMed ID: 33968511
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Alpelisib-Induced Diabetic Ketoacidosis in a Patient With Metastatic Breast Cancer.
    Abufaied M; Jumbo U; Alqalalwah A; Hamad MK
    Cureus; 2021 Nov; 13(11):e19441. PubMed ID: 34909343
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin.
    Kaur A; Winters SJ
    Endocrinol Diabetes Metab Case Rep; 2015; 2015():150042. PubMed ID: 26191411
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Metabolic ketoacidosis with normal blood glucose: A rare complication of sodium-glucose cotransporter 2 inhibitors.
    Ullah S; Khan N; Zeb H; Tahir H
    SAGE Open Med Case Rep; 2016; 4():2050313X16675259. PubMed ID: 27928503
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Sudden-onset Hypoglycemia Following Fluid Replacement in a Patient with Dapagliflozin-induced Diabetic Ketoacidosis Without Prior Insulin Use: Case Report.
    Elshimy G; Correa R
    Cureus; 2019 Aug; 11(8):e5448. PubMed ID: 31489272
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Euglycaemic diabetic ketoacidosis in bariatric surgery patients with type 2 diabetes taking canagliflozin.
    van Niekerk C; Wallace J; Takata M; Yu R
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30131409
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A Case of Concomitant COVID-19 Infection-Induced Acute Respiratory Distress Syndrome and Diabetic Ketoacidosis: Another Challenge in Fluid Management.
    Panjawatanan P; Jha S; Hughes J; Riesenfeld E
    Cureus; 2020 Nov; 12(11):e11805. PubMed ID: 33409050
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.
    Blau JE; Tella SH; Taylor SI; Rother KI
    Diabetes Metab Res Rev; 2017 Nov; 33(8):. PubMed ID: 28736981
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The effect of combined treatment with canagliflozin and teneligliptin on glucose intolerance in Zucker diabetic fatty rats.
    Oguma T; Kuriyama C; Nakayama K; Matsushita Y; Yoshida K; Kiuchi S; Ikenaga Y; Nakamaru Y; Hikida K; Saito A; Arakawa K; Oka K; Ueta K; Shiotani M
    J Pharmacol Sci; 2015 Apr; 127(4):456-61. PubMed ID: 25892328
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature.
    Lucero P; Chapela S
    Case Rep Crit Care; 2018; 2018():1747850. PubMed ID: 30364093
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Ketoacidosis With Canagliflozin Prescribed for Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia: A Case Report.
    Bowman C; Abramson V; Wellons M
    J Investig Med High Impact Case Rep; 2017; 5(3):2324709617725351. PubMed ID: 28856166
    [No Abstract]   [Full Text] [Related]  

  • 96. Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis.
    Rafey MF; Butt A; Coffey B; Reddington L; Devitt A; Lappin D; Finucane FM
    Endocrinol Diabetes Metab Case Rep; 2019 Sep; 2019():. PubMed ID: 31600728
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Non-occlusive Mesenteric Ischemia with Diabetic Ketoacidosis and Lactic Acidosis Following the Administration of a Sodium Glucose Co-transporter 2 Inhibitor.
    Gocho N; Aoki E; Okada C; Omura K; Hirashima T; Suzuki N; Tanaka H; Omori Y
    Intern Med; 2016; 55(13):1755-60. PubMed ID: 27374678
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma.
    Wu L; Li B
    Diabetes Metab Syndr Obes; 2021; 14():753-757. PubMed ID: 33628041
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Hyperkalemic Cardiac Arrest in a Patient with Diabetic Ketoacidosis.
    Manappallil RG; Nambiar J
    Indian J Crit Care Med; 2020 Aug; 24(8):737-738. PubMed ID: 33024389
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes.
    Hassani-Ardakania K; Lipman ML; Laporta D; Yu OHY
    Case Rep Endocrinol; 2019; 2019():8639629. PubMed ID: 31275667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.